TrialMedical oncology (Northwood, London, England)2013
A phase II study of biweekly paclitaxel and cisplatin chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma: ERCC1 expression predicts response to chemotherapy.
Jing Huang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this paperpooled ittrialcites it